{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T16:59:41Z","timestamp":1768323581573,"version":"3.49.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"4-5","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.clinbiochem.2013.12.015","type":"journal-article","created":{"date-parts":[[2014,1,2]],"date-time":"2014-01-02T23:35:48Z","timestamp":1388705748000},"page":"293-299","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Developing an institutional cancer biorepository for personalized medicine"],"prefix":"10.1016","volume":"47","author":[{"given":"Angen","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2013.12.015_bb0005","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/jso.23309","article-title":"Biospecimen banking: the pathway to personalized medicine for patients with cancer","volume":"107","author":"Scolyer","year":"2013","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.clinbiochem.2013.12.015_bb0010","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/CCO.0b013e32834161b8","article-title":"Biobanking: the foundation of personalized medicine","volume":"23","author":"Hewitt","year":"2011","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.clinbiochem.2013.12.015_bb0015","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nature12222","article-title":"Comprehensive molecular characterization of clear cell renal cell carcinoma","volume":"499","author":"Cancer Genome Atlas Research Network","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.clinbiochem.2013.12.015_bb0020","doi-asserted-by":"crossref","first-page":"895","DOI":"10.2217\/bmm.10.104","article-title":"Human tissue biobanks as instruments for drug discovery and development: impact on personalized medicine","volume":"4","author":"Zatloukal","year":"2010","journal-title":"Biomark Med"},{"key":"10.1016\/j.clinbiochem.2013.12.015_bb0025","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/QAD.0b013e32835c1244","article-title":"Biobanking past, present and future: responsibilities and benefits","volume":"27","author":"De Souza","year":"2013","journal-title":"AIDS"},{"key":"10.1016\/j.clinbiochem.2013.12.015_bb0030","author":"National Cancer Institute"},{"key":"10.1016\/j.clinbiochem.2013.12.015_bb0035","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1089\/bio.2012.1022","article-title":"2012 best practices for repositories collection, storage, retrieval, and distribution of biological materials for research","volume":"10","author":"International Society for Biological, Environmental Repositories (ISBER)","year":"2012","journal-title":"Biopreservation and Biobanking"},{"key":"10.1016\/j.clinbiochem.2013.12.015_bb0040","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1158\/1055-9965.EPI-06-0632","article-title":"Biorepository and biospecimen science: a new focus for CEBP","volume":"15","author":"Vaught","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.clinbiochem.2013.12.015_bb0045","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1158\/1055-9965.EPI-11-1179","article-title":"Biospecimens and biorepositories: from afterthought to science","volume":"21","author":"Vaught","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.clinbiochem.2013.12.015_bb0050","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1056\/NEJMoa1006448","article-title":"Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer","volume":"363","author":"Kwak","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinbiochem.2013.12.015_bb0055","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1056\/NEJMoa040938","article-title":"Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib","volume":"350","author":"Lynch","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinbiochem.2013.12.015_bb0060","doi-asserted-by":"crossref","first-page":"13306","DOI":"10.1073\/pnas.0405220101","article-title":"EGF receptor gene mutations are common in lung cancers from \u201cnever smokers\u201d and are associated with sensitivity of tumors to gefitinib and erlotinib","volume":"101","author":"Pao","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.clinbiochem.2013.12.015_bb0065","doi-asserted-by":"crossref","first-page":"e13302","DOI":"10.1371\/journal.pone.0013302","article-title":"Developing a simplified consent form for biobanking","volume":"5","author":"Beskow","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.clinbiochem.2013.12.015_bb0070","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1097\/GIM.0b013e31821d2f88","article-title":"Active choice but not too active: public perspectives on biobank consent models","volume":"13","author":"Simon","year":"2011","journal-title":"Genet Med"},{"key":"10.1016\/j.clinbiochem.2013.12.015_bb0075","author":"Code of Federal Regulations"},{"key":"10.1016\/j.clinbiochem.2013.12.015_bb0080","author":"Code of Federal Regulations"},{"key":"10.1016\/j.clinbiochem.2013.12.015_bb0085","first-page":"368751","article-title":"Tissue banking, bioinformatics, and electronic medical records: the front-end requirements for personalized medicine","author":"Suh","year":"2013","journal-title":"J Oncol"},{"key":"10.1016\/j.clinbiochem.2013.12.015_bb0090","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.socscimed.2009.10.004","article-title":"\u201cBroad\u201d consent, exceptions to consent and the question of using biological samples for research purposes different from the initial collection purpose","volume":"70","author":"Petrini","year":"2010","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.clinbiochem.2013.12.015_bb0095","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1258\/jhsrp.2008.008085","article-title":"Feasibility and cost of obtaining informed consent for essential review of medical records in large-scale health services research","volume":"14","author":"Noble","year":"2009","journal-title":"J Health Serv Res Policy"},{"key":"10.1016\/j.clinbiochem.2013.12.015_bb0100","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/clpt.2008.89","article-title":"Development of a large-scale de-identified DNA biobank to enable personalized medicine","volume":"84","author":"Roden","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.clinbiochem.2013.12.015_bb0105","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1752-8062.2010.00175.x","article-title":"Principles of human subjects protections applied in an opt-out, de-identified biobank","volume":"3","author":"Pulley","year":"2010","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.clinbiochem.2013.12.015_bb0110","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/gim.2012.23","article-title":"Managing incidental findings and research results in genomic research involving biobanks and archived data sets","volume":"14","author":"Wolf","year":"2012","journal-title":"Genet Med"},{"key":"10.1016\/j.clinbiochem.2013.12.015_bb0115","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1748-720X.2008.00266.x","article-title":"Managing incidental findings in human subjects research: analysis and recommendations","volume":"36","author":"Wolf","year":"2008","journal-title":"J Law Med Ethics"},{"key":"10.1016\/j.clinbiochem.2013.12.015_bb0120","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1136\/amiajnl-2012-000960","article-title":"Challenges in creating an opt-in biobank with a registrar-based consent process and a commercial EHR","volume":"19","author":"Marsolo","year":"2012","journal-title":"J Am Med Inform Assoc"},{"key":"10.1016\/j.clinbiochem.2013.12.015_bb0125","first-page":"67","volume":"1","author":"National Bioethics Advisory Commission","year":"1999"},{"key":"10.1016\/j.clinbiochem.2013.12.015_bb0130","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrclinonc.2013.101","article-title":"Biopsies: next-generation biospecimens for tailoring therapy","volume":"10","author":"Basik","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.clinbiochem.2013.12.015_bb0135","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1038\/modpathol.2013.81","article-title":"Next-generation biobanking of metastases to enable multidimensional molecular profiling in personalized medicine","volume":"26","author":"Diaz","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1016\/j.clinbiochem.2013.12.015_bb0140","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/S0002-9440(10)64451-3","article-title":"Changes in differential gene expression because of warm ischemia time of radical prostatectomy specimens","volume":"161","author":"Dash","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.clinbiochem.2013.12.015_bb0145","first-page":"2073","article-title":"Ischemic time impacts biological integrity of phospho-proteins in PI3K\/Akt, Erk\/MAPK, and p38 MAPK signaling networks","volume":"31","author":"Holzer","year":"2011","journal-title":"Anticancer Res"},{"key":"10.1016\/j.clinbiochem.2013.12.015_bb0150","first-page":"120","article-title":"Laser capture microdissection in the tissue biorepository","volume":"21","author":"Liu","year":"2010","journal-title":"J Biomol Tech"},{"key":"10.1016\/j.clinbiochem.2013.12.015_bb0155","author":"College of American Pathologits"},{"key":"10.1016\/j.clinbiochem.2013.12.015_bb0160","series-title":"Clinical Laboratory Improvement Amendments of 1988, 42 U.S.C. 263a PL100-578","year":"1988"},{"key":"10.1016\/j.clinbiochem.2013.12.015_bb0165","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1309\/AJCP7DWCQ1SWJTWU","article-title":"A new paradigm for biospecimen banking in the personalized medicine era","volume":"136","author":"McDonald","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.clinbiochem.2013.12.015_bb0170","doi-asserted-by":"crossref","first-page":"288","DOI":"10.4048\/jbc.2012.15.3.288","article-title":"Survival benefit of tamoxifen in estrogen receptor-negative and progesterone receptor-positive low grade breast cancer patients","volume":"15","author":"Yang","year":"2012","journal-title":"J Breast Cancer"},{"key":"10.1016\/j.clinbiochem.2013.12.015_bb0175","first-page":"141","article-title":"Anastrozole use in early stage breast cancer of post-menopausal women","volume":"1","author":"Milani","year":"2009","journal-title":"Clin Med Ther"},{"key":"10.1016\/j.clinbiochem.2013.12.015_bb0180","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10549-012-2395-8","article-title":"Comparing duration of response and duration of clinical benefit between fulvestrant treatment groups in the CONFIRM trial: application of new methodology","volume":"138","author":"Garnett","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clinbiochem.2013.12.015_bb0190","first-page":"1","article-title":"A decade of experience in the development and implementation of tissue banking informatics tools for intra and inter-institutional translational research","author":"Amin","year":"2010","journal-title":"J Pathol Inform"},{"key":"10.1016\/j.clinbiochem.2013.12.015_bb0195","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/QAD.0b013e32835c1244","article-title":"Biobanking past, present and future: responsibilities and benefits","volume":"27","author":"De Souza","year":"2013","journal-title":"AIDS"},{"key":"10.1016\/j.clinbiochem.2013.12.015_bb0200","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/1471-2407-8-236","article-title":"National Mesothelioma Virtual Bank: a standard based biospecimen and clinical data resource to enhance translational research","volume":"8","author":"Amin","year":"2008","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clinbiochem.2013.12.015_bb0205","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1002\/cncr.23768","article-title":"A multidisciplinary approach to honest broker services for tissue banks and clinical data: a pragmatic and practical model","volume":"113","author":"Dhir","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.clinbiochem.2013.12.015_bb0210","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/gim.2012.26","article-title":"The past, present, and future of the debate over return of research results and incidental findings","volume":"14","author":"Wolf","year":"2012","journal-title":"Genet Med"},{"key":"10.1016\/j.clinbiochem.2013.12.015_bb0215","series-title":"Recommendations for returning genomic incidental findings? We need to talk! Genet Med","author":"Burke","year":"2013"},{"key":"10.1016\/j.clinbiochem.2013.12.015_bb0220","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nrclinonc.2011.121","article-title":"Predictive biomarkers: a paradigm shift towards personalized cancer medicine","volume":"8","author":"La Thangue","year":"2011","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.clinbiochem.2013.12.015_bb0225","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0910383","article-title":"Adjuvant trastuzumab in HER2-positive breast cancer","volume":"365","author":"Slamon","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinbiochem.2013.12.015_bb0230","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","article-title":"BRIM-3 Study Group. Improved survival with vemurafenib in melanoma with BRAF V600E mutation","volume":"364","author":"Chapman","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinbiochem.2013.12.015_bb0235","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1517\/14656566.2012.688029","article-title":"Crizotinib in the treatment of non-small-cell lung cancer","volume":"13","author":"Forde","year":"2012","journal-title":"Expert Opin Pharmacother"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912013006000?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912013006000?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:42:50Z","timestamp":1757864570000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912013006000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":46,"journal-issue":{"issue":"4-5","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0009912013006000"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2013.12.015","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Developing an institutional cancer biorepository for personalized medicine","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2013.12.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}